NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
10/27/2021
Back to search
Official data from USPTO
PRADAXA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
10/27/2021
Trademark type
Word
Nice classes
5
Filing date
09/20/2010
Registration date
06/14/2011
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/27/2021
Last transaction
10/27/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
10/26/2010
First use in commerce
10/26/2010
Drawing code
4
Owner type
99
Owner location
Ingelheim, DE
Examiner
SEVERSON, KAREN
Law office
M80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Boehringer Ingelheim Pharma GmbH & Co., KG
Representatives
Sean P. McMahon OSTROLENK FABER LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of blood and blood forming organs as well as for the treatment of the cardiovascular system
Publications
History of USPTO decisions and trademark events.
33 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
10/27/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
10/27/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/27/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
06/14/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/14/2020
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
07/21/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
07/21/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/21/2017
E815
TEAS SECTION 8 & 15 RECEIVED
05/31/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
06/14/2011
PUBO
PUBLISHED FOR OPPOSITION
03/29/2011
NPUB
NOTICE OF PUBLICATION
03/09/2011
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
02/23/2011
AAUA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE MAILED
02/23/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/22/2011
IUAA
USE AMENDMENT ACCEPTED
02/22/2011
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
02/22/2011
IUAF
USE AMENDMENT FILED
02/22/2011
ZZAX
PREVIOUS ALLOWANCE WITHDRAWN-TIMELY AAU
02/22/2011
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/09/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2011
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/04/2011
PAPER RECEIVED
02/03/2011
ACEC
AMENDMENT FROM APPLICANT ENTERED
02/03/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/03/2011
ALIE
ASSIGNED TO LIE
01/28/2011
PAPER RECEIVED
01/14/2011
CEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
12/28/2010
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
12/28/2010
DOCK
ASSIGNED TO EXAMINER
12/28/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/23/2010
NWAP
NEW APPLICATION ENTERED
09/23/2010
Continuous trademark protection
Get notified about every new filing that threatens PRADAXA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.